🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
Assessment of the effect of BI 1356 or Placebo on prolongation of the QT in...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT02183467
Treatments Being Tested
Study to investigate the safety, tolerability, pharmacokinetics, and pharma...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT02183415
Treatments Being Tested
This trial will evaluate use of BI 10773/linagliptin once daily (qd) fixed ...
Status
Completed
Location
1275.1.01103 Boehringer Ingelheim Investigational Site
Start Date
2011-08
Trial ID
NCT01422876
Treatments Being Tested
Study to evaluate the safety, tolerability, pharmacokinetics, and pharmacod...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT02183324
Treatments Being Tested
Investigation of the relative bioavailability of 1 mg and 10 mg BI 1356 BS ...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT02180503
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.23.05 Boehringer Ingelheim Investigational Site
Start Date
2008-04
Trial ID
NCT00654381
Treatments Being Tested
The objective of the randomised part of the study is to investigate the eff...
Status
Completed
Location
1218.46.11005 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00798161
Treatments Being Tested
The objective was to investigate the influence of 2 different dosage regime...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT02173652
Treatments Being Tested